METAVIA INC. Total Liabilities and Equity
METAVIA INC. (MTVA) had Total Liabilities and Equity of $13.27 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-06
- 2026-06-30: Liabilities and Equity $13.27M.
- 2026-03-31: Liabilities and Equity $14.39M.
- 2025-12-31: Liabilities and Equity $11.12M.
- 2025-09-30: Liabilities and Equity $14.77M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $13.27M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $14.39M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $11.12M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $14.77M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $18.46M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $12.13M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $16.26M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $22.15M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $28.75M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $17.02M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $22.78M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $26.43M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $29.18M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $31.49M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $33.53M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $7.56M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $10.08M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $13.46M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $16.80M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $8.08M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $10.72M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $14.16M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $10.97M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $13.20M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $15.55M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $11.54M 10-Q · filed 2020-05-20 | |
| 2019-12-31 | $14.47M 10-K · filed 2021-04-15 | |
| 2019-09-30 | $2.05M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $4.01M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $6.16M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.82M 10-K · filed 2020-03-30 | $19.69M 10-K · filed 2019-03-18 |
| 2018-09-30 | $24.87M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $28.81M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $34.84M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $19.02M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $26.21M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $23.00M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $29.84M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $24.75M 10-K · filed 2018-03-20 | |
| 2016-09-30 | $28.92M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $6.73M 10-Q · filed 2016-09-14 | |
| 2015-12-31 | $4.49M 10-K · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |